Xialin Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xialin Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Duan Yang
Department of Spine Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
1 shared publication - Guangxun Hu
Department of Orthopedics, Shenzhen Nanshan People's Hospital, Shenzhen 518052, China
1 shared publication - Junfeng Gong
Department of General Surgery, The Armed Police Corps Hospital of Anhui, Hefei, China
1 shared publication - Min Shu
Department of Emergency, Shenzhen Nanshan People's Hospital, Shenzhen 518052, China
1 shared publication - Songjia Ni
Department of Traumatic Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, China
1 shared publication - Weihong Yi
Department of Orthopedics, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, Guangdong, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1) , 2705953
Bone Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Protect Articular Cartilage Through Regulating tRF‐Gln‐TTG‐019/UBL3
The tRNA‐derived fragments (tRFs) are newly discovered noncoding RNAs enriched in extracellular vesicles (EVs). However, the effects of tRFs as biomarkers have not been investigated in cartilage repair. Bone mesenchymal stromal cells (BMSCs) were isolated from male Sprague Dawley (SD) rats, and high‐throughput sequencing was used to select tRFs from EVs derived from BMSC which were cultured in chondrogenic induction medium (induced) or stem cell growth medium (control). We established the rat cartilage defect model of the knee joint, in which physiological changes were examined by immunohistochemistry (IHC), to test the protective effect of BMSC‐derived EVs and tRF‐related molecules. Primary chondrocytes from rat knee joint treated with oxygen–glucose deprivation/reperfusion (OGD/R) were used to investigate the effect of related EVs and tRF on cell proliferation and apoptosis. BMSC‐derived EVs could repair the defected cartilage of rat knee joint. OGD/R significantly reduced chondrocytes proliferation, induced chondrocyte apoptosis and inflammation, while BMSC‐derived EVs reversed these effects. Additionally, tRF‐Gln‐TTG‐019 significantly increased in EVs derived from differentiated BMSCs when compared with control group. Knockdown ubiquitin‐like 3 (UBL3, a molecular target of tRF‐Gln‐TTG‐019) inhibited chondrocytes apoptosis and inflammation induced by OGD/R, and this effect could be synergistically enhanced when co‐cultured with BMSC‐EVs, but the protection was partly reversed by tRF‐Gln‐TTG‐019 inhibitor. Then we further validated that suppression of UBL3 could promote the proliferation of chondrocytes, inhibit inflammation, and enhance the repair ability of cartilage tissue in a rat cartilage defect model. Similarly to the previous results, BMSC‐derived EVs could synergistically enhance these effects, while tRF‐Gln‐TTG‐019 inhibitor weakened them. Our results indicate that tRF in BMSC‐derived EVs modulates the process of cartilage repair by regulating UBL3.
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1) , 2705953
Open AccessBone Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Protect Articular Cartilage Through Regulating tRF‐Gln‐TTG‐019/UBL3
The tRNA‐derived fragments (tRFs) are newly discovered noncoding RNAs enriched in extracellular vesicles (EVs). However, the effects of tRFs as biomarkers have not been investigated in cartilage repair. Bone mesenchymal stromal cells (BMSCs) were isolated from male Sprague Dawley (SD) rats, and high‐throughput sequencing was used to select tRFs from EVs derived from BMSC which were cultured in chondrogenic induction medium (induced) or stem cell growth medium (control). We established the rat cartilage defect model of the knee joint, in which physiological changes were examined by immunohistochemistry (IHC), to test the protective effect of BMSC‐derived EVs and tRF‐related molecules. Primary chondrocytes from rat knee joint treated with oxygen–glucose deprivation/reperfusion (OGD/R) were used to investigate the effect of related EVs and tRF on cell proliferation and apoptosis. BMSC‐derived EVs could repair the defected cartilage of rat knee joint. OGD/R significantly reduced chondrocytes proliferation, induced chondrocyte apoptosis and inflammation, while BMSC‐derived EVs reversed these effects. Additionally, tRF‐Gln‐TTG‐019 significantly increased in EVs derived from differentiated BMSCs when compared with control group. Knockdown ubiquitin‐like 3 (UBL3, a molecular target of tRF‐Gln‐TTG‐019) inhibited chondrocytes apoptosis and inflammation induced by OGD/R, and this effect could be synergistically enhanced when co‐cultured with BMSC‐EVs, but the protection was partly reversed by tRF‐Gln‐TTG‐019 inhibitor. Then we further validated that suppression of UBL3 could promote the proliferation of chondrocytes, inhibit inflammation, and enhance the repair ability of cartilage tissue in a rat cartilage defect model. Similarly to the previous results, BMSC‐derived EVs could synergistically enhance these effects, while tRF‐Gln‐TTG‐019 inhibitor weakened them. Our results indicate that tRF in BMSC‐derived EVs modulates the process of cartilage repair by regulating UBL3.
- Open Access
- 6 January 2024
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 58 (6) , 353-357
Assessment of factors implicated in bone fusion after percutaneous endoscopic lumbar intervertebral fusion
Objective: Lumbar spinal fusion is a common procedure for treating spinal degenerative diseases. Percutaneous endoscopic lumbar interbody fusion (PELIF) is a minimally invasive technique that has gained popularity. However, the factors influencing fusion success rates after PELIF have not been well-studied. Methods: This single-center retrospective study reviewed the medical records of 96 patients who underwent single-level PELIF for degenerative pathologies between 2018 and 2020. Fusion was evaluated using thin-slice computed tomography scans at 12 months by 2 independent radiologists and defined as no detectable lucency between bone and graft. Patients were categorized into fusion and non-fusion groups. Data on age, operative time, blood loss, drainage, hospital stay, surgical level, osteoporosis, endplateitis, body mass index, lumbar curvature, and bone morphogenetic protein (BMP) use were collected. Univariate tests (chi-square, Student’s t-test, and analysis of variance) were employed to compare factors between groups. Significant factors were included in a multivariate logistic regression model with fusion as the dependent variable. Results: The overall fusion success rate was 85.6% (86 fusion and 10 non-fusion). Univariate analysis revealed significant di!erences in age, osteoporosis, hypertension, diabetes, endplateitis, and BMP use between groups. Multivariate analysis identified osteoporosis (odds ratio (OR)=5.44, 95% CI, P < .05) and end-plate osteochondritis (OR=10.449, 95% CI, P < .05) as independent risk factors for non-fusion. Conclusion: The use of BMP and endplateitis are significant factors that a!ect bone fusion outcomes after the PELIF procedure. These factors should be taken into account in order to improve postoperative bone fusion. Level of Evidence: Level IV, Therapeutic Study Cite this article as: Huang Z, Li X, Yi W, Gong J, Zhou Y, Tang Y. Assessment of factors implicated in bone fusion after percutaneous endoscopic lumbar intervertebral fusion. Acta Orthop Traumatol Turc., 2024;58(6):353-357.
- 6 January 2024
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 58 (6) , 353-357
Open AccessAssessment of factors implicated in bone fusion after percutaneous endoscopic lumbar intervertebral fusion
Objective: Lumbar spinal fusion is a common procedure for treating spinal degenerative diseases. Percutaneous endoscopic lumbar interbody fusion (PELIF) is a minimally invasive technique that has gained popularity. However, the factors influencing fusion success rates after PELIF have not been well-studied. Methods: This single-center retrospective study reviewed the medical records of 96 patients who underwent single-level PELIF for degenerative pathologies between 2018 and 2020. Fusion was evaluated using thin-slice computed tomography scans at 12 months by 2 independent radiologists and defined as no detectable lucency between bone and graft. Patients were categorized into fusion and non-fusion groups. Data on age, operative time, blood loss, drainage, hospital stay, surgical level, osteoporosis, endplateitis, body mass index, lumbar curvature, and bone morphogenetic protein (BMP) use were collected. Univariate tests (chi-square, Student’s t-test, and analysis of variance) were employed to compare factors between groups. Significant factors were included in a multivariate logistic regression model with fusion as the dependent variable. Results: The overall fusion success rate was 85.6% (86 fusion and 10 non-fusion). Univariate analysis revealed significant di!erences in age, osteoporosis, hypertension, diabetes, endplateitis, and BMP use between groups. Multivariate analysis identified osteoporosis (odds ratio (OR)=5.44, 95% CI, P < .05) and end-plate osteochondritis (OR=10.449, 95% CI, P < .05) as independent risk factors for non-fusion. Conclusion: The use of BMP and endplateitis are significant factors that a!ect bone fusion outcomes after the PELIF procedure. These factors should be taken into account in order to improve postoperative bone fusion. Level of Evidence: Level IV, Therapeutic Study Cite this article as: Huang Z, Li X, Yi W, Gong J, Zhou Y, Tang Y. Assessment of factors implicated in bone fusion after percutaneous endoscopic lumbar intervertebral fusion. Acta Orthop Traumatol Turc., 2024;58(6):353-357.